Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients with Sickle Cell Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The purpose of this study is to determine whether a single infusion of tocilizumab is effective in reducing the time to successful weaning from both supplemental oxygen and any respiratory support, in pediatric and adult patients with sickle cell disease (SCD) during acute chest syndrome (ACS).
Epistemonikos ID: 0cda3fba5d157a01b605d0b21cfe9b6b264717dd
First added on: Mar 27, 2025